Hims & Hers Health, Inc.

HIMS·NYSE·Healthcare
Compare
30.92+2.86 (+10.19%)today
At close: Oct 9, 4:00 PM EDT · Real-time · USD
After hours30.93+0.01 (+0.03%)Oct 9, 7:59 PM EDT

Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close28.06
Open28.34
Day range28.3131.45
52-week range13.7465.30
Volume15.95M
Avg. volume (3M)12.11M
Market cap7.21B
P/E ratio (TTM)—
Forward P/E41.94
EPS (TTM)-0.6400
Dividend yield—
Beta (5Y)2.43
Shares outstanding224.94M
Earnings dateAug 10, 2026
Analyst target31.15
Profit margin−5.51%

Latest news

All HIMS news ›
Yahoo Finance·

Hims & Hers Health, Inc. (HIMS)

Stock Price, News, Quote & History Yahoo! Finance Canada Oops, something went wrong Hims & Hers Health, Inc. (HIMS) Hims & Hers Health, Inc. Overview Drug Manufacturers - Specialty & Generic / Healthcare Hims & Hers Health, Inc. operates…

Seeking Alpha·Upbeat

Hims & Hers Health climbs 10% amid recent volatile trading

(HIMS:NYSE) Seeking Alpha SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. vorDa/E+ via Getty Images Shares of Hims & Hers Health (HIMS), a…

The Globe and Mail·

Reasons to Retain Hims & Hers Stock in Your Portfolio for Now

Hims & Hers Health HIMS has entered the last quarter of 2026 with strong momentum from weight loss offerings, international expansion and AI-enabled care. However, gross margin pressure from changing business mix, regulatory uncertainty…

From articles in the 4Search news index.

In the news

217mentions in 30 days
36with it in the headline
Mixedheadline tone

Measured across the 4TOOLS news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.

Market data is provided for information only and comes from free public sources. Quotes are marked real-time or delayed as their source reports them; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4TOOLS index. Terms of use.